The AI Infectious Disease & Vaccines Research Intelligence agent — pathogen to protection.
A scientific research agent (not a chatbot, not a diagnostic tool) that discovers, connects, analyses, challenges and synthesises infectious-disease & vaccine knowledge from authorized literature, databases, datasets and enterprise tools — to help you understand what is known, what is unknown, what may be true, what has failed and what to test next.
Twelve deeply-connected knowledge domains spanning the research lifecycle.
Bacterial, viral, fungal & parasitic diseases — respiratory viruses, HIV, hepatitis, TB, malaria, sepsis, hospital-acquired & emerging pathogens with pandemic potential.
Microbial physiology, virulence factors, host–pathogen interaction, immune evasion, latency & persistence, the human immune response and the microbiome's protective role.
Pathogen whole-genome sequencing, phylogenetics, variant tracking, host genetics of susceptibility and metagenomic surveillance — connected pathogen → host → population.
Resistance mechanisms & genes, mobile genetic elements, fitness costs, stewardship and the pipeline gap — a central threat framing target and combination strategy.
Essential-gene, structural and reverse-vaccinology evidence for antimicrobial targets and protective antigens — with tractability, conservation, escape risk and prior failures separated.
mRNA, viral-vector, subunit, conjugate & live-attenuated platforms, adjuvants, correlates of protection and manufacturing/cold-chain constraints across the development cascade.
Small molecules, mAbs, phage & host-directed therapies — mechanism, spectrum, PK/PD, combinations and resistance-breaking strategies across discovery to development.
Rapid, molecular and point-of-care diagnostics, host-response signatures and correlates of protection — with performance, validation and clinical-utility context.
Design, population, endpoints (efficacy, VE, time-to-clearance), human-challenge models, comparators, results and adverse events — surfacing failed hypotheses and design opportunities.
Transmission & outbreak modelling, phylodynamics, survival analysis, causal inference and predictive modelling on authorized surveillance and trial datasets.
Reasons across Pathogen ↔ Gene ↔ Antigen ↔ Host ↔ Immune response ↔ Biomarker ↔ Target ↔ Drug/Vaccine ↔ Trial ↔ Outcome, with every claim traceable to primary sources.
Finds resistance blind spots, correlate-of-protection gaps, neglected pathogens and under-studied populations — then frames testable hypotheses and experiments.
Surface novel, testable research directions and drug-repurposing leads across the whole ecosystem — not a single paper.
Integrate literature, omics, trials and real-world data into one traceable evidence graph so hidden connections become visible.
A built-in scientific critic tests for confounding, batch effects, power, publication bias, replication and prior failures.
Research questions, proposals, protocols, SAPs, reviews and manuscript scaffolds — never fabricating data, patients, stats or citations.
Statements are tagged so you always know their standing — and confidence is stated, never inflated. Citations, DOIs, PMIDs, dataset and trial IDs are drawn from primary sources; if a source can't be verified it says so. Infectious Disease & Vaccines Genius is a research-intelligence system, not a substitute for a physician — it does not diagnose or treat individuals.
We use cookies to run Anxya Health and improve your experience. Choose how we may use them. Read our Cookie Policy, Privacy Policy and Terms.